LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

JPMorgan Chase raises key revenue target to $84 billion after First Republic takeover

Garry Wills by Garry Wills
May 22, 2023
in Business Finance
JPMorgan Chase raises key revenue target to  billion after First Republic takeover
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


Jamie Dimon, chairman and chief executive officer of JPMorgan Chase & Co., during a Bloomberg Television interview at the JPMorgan Global High Yield and Leveraged Finance Conference in Miami, Florida, US, on Monday, March 6, 2023.

Marco Bello | Bloomberg | Getty Images

JPMorgan Chase raised a key performance target on the heels of its government-brokered takeover of First Republic earlier this month.

The bank will generate about $84 billion in net interest income this year, the New York-based bank said Monday in slides for an all-day investor presentation.

related investing news

CNBC Pro

That’s $3 billion higher than guidance given in April. At the time, JPMorgan raised its net interest income outlook by $7 billion, a move that spurred JPMorgan’s biggest earnings-day stock bump in 20 years.

The bank added that “sources of uncertainty” around deposits and the economy could impact its forecast. Net interest income is the difference between what banks earn from loans and investments and what they pay to depositors.

JPMorgan, the biggest U.S. bank by assets, has emerged as a beneficiary of the recent regional banking tumult. It was one of the only banks to see deposits climb in the first quarter as panicked customers sought safety at big institutions; then it won a weekend auction for First Republic, a move expected to boost earnings and advance its push for wealthy clients.

The bank on Monday also disclosed expectations that expenses would rise to $84.5 billion, unchanged from previous guidance, excluding $3.5 billion in costs to integrate First Republic.  

Longtime JPMorgan CEO Jamie Dimon is expected to speak in a question-and-answer session at the investor day this afternoon.

He will likely be asked about the U.S. debt ceiling negotiations, as well as succession planning after rival CEO James Gorman of Morgan Stanley last week announced plans to step down within a year.

This story is developing. Please check back for updates.



Source link

You might also like

Venezuela shows how locals turn to Tether-issued USDT stablecoin as governments wobble

Alibaba-backed startup Moonshot AI’s valuation is up $500 million, sources say, after its rivals IPO in Hong Kong

Chinese EV giant BYD is a buy — and not just for its cars, Bernstein says

Share30Tweet19
Previous Post

‘This is why built-to-rent will outperform BTL in the long term’ – LandlordZONE

Next Post

Intercept Pharmaceuticals stock tumbles toward 11-month low after disappointing FDA committee vote

Garry Wills

Garry Wills

Recommended For You

Venezuela shows how locals turn to Tether-issued USDT stablecoin as governments wobble
Business Finance

Venezuela shows how locals turn to Tether-issued USDT stablecoin as governments wobble

January 19, 2026
Alibaba-backed startup Moonshot AI’s valuation is up 0 million, sources say, after its rivals IPO in Hong Kong
Business Finance

Alibaba-backed startup Moonshot AI’s valuation is up $500 million, sources say, after its rivals IPO in Hong Kong

January 19, 2026
Chinese EV giant BYD is a buy — and not just for its cars, Bernstein says
Business Finance

Chinese EV giant BYD is a buy — and not just for its cars, Bernstein says

January 18, 2026
Trump threatens to sue JPMorgan Chase for ‘debanking’ him
Business Finance

Trump threatens to sue JPMorgan Chase for ‘debanking’ him

January 17, 2026
Next Post
Intercept Pharmaceuticals stock tumbles toward 11-month low after disappointing FDA committee vote

Intercept Pharmaceuticals stock tumbles toward 11-month low after disappointing FDA committee vote

Related News

After shocking bankruptcy, anti-VanMoof e-bikes like these may be the answer

After shocking bankruptcy, anti-VanMoof e-bikes like these may be the answer

July 24, 2023
Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings

Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings

October 28, 2025
China VCs have a big problem — and it’s not just a drop in U.S. investor appetite

China VCs have a big problem — and it’s not just a drop in U.S. investor appetite

September 19, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • jutawantoto
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?